The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Mar. 05, 2024

Filed:

Mar. 18, 2021
Applicant:

Johnson & Johnson Consumer Inc., Skillman, NJ (US);

Inventors:

Curt Binner, Furlong, PA (US);

Justin Mellinger, Philadelphia, PA (US);

Alexandru Paunescu, Clinton, NJ (US);

Assignee:

Johnson & Johnson Consumer Inc., Skillman, NJ (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
G01N 21/78 (2006.01); A61F 13/42 (2006.01); A61F 13/49 (2006.01); B01L 3/00 (2006.01); C12Q 1/26 (2006.01); C12Q 1/28 (2006.01); C12Q 1/54 (2006.01); G01N 21/31 (2006.01); G01N 33/493 (2006.01); G01N 33/52 (2006.01); G01N 21/77 (2006.01);
U.S. Cl.
CPC ...
G01N 21/78 (2013.01); A61F 13/42 (2013.01); A61F 13/49 (2013.01); B01L 3/502707 (2013.01); B01L 3/502761 (2013.01); B01L 3/502776 (2013.01); C12Q 1/26 (2013.01); C12Q 1/28 (2013.01); C12Q 1/54 (2013.01); G01N 21/31 (2013.01); G01N 33/493 (2013.01); G01N 33/52 (2013.01); B01L 2200/10 (2013.01); G01N 2021/7756 (2013.01); G01N 2021/7766 (2013.01); G01N 2201/062 (2013.01);
Abstract

A method for predicting risk of a future disease condition includes the steps of collecting and transporting bodily fluid to at least one colorimetric analyte sensing element, detecting the presence of bodily fluid, collecting optical data relating to the at least one colorimetric analyte sensing element with at least one spectrophotometer after a predetermined time period after detecting the presence of bodily fluid in contact with the colorimetric analyte sensing element, communicating the optical data to a computing system having at least one processor and data storage, analyzing the optical data to determine at least one analyte concentration in the bodily fluid, identifying a threshold analyte concentration of the at least one analyte in the bodily fluid that is an indicator of the risk of developing a future disease condition; and recording the at least one analyte concentration in the bodily fluid over time.


Find Patent Forward Citations

Loading…